| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Morningside Venture Investments Ltd is a 10% Owner at Apellis Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 15 sells.
Estimated insider holdings value: $615.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 60,000 | $7.00 | $419,700.00 | -0.5% | -65.3% | -86.2% | |
| Jan 25, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 50,000 | $6.85 | $342,500.00 | -0.9% | -64.0% | -87.9% | |
| Jan 24, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 160,000 | $6.90 | $1,103,200.00 | -1.4% | -64.9% | -88.5% | |
| Jan 17, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 6,114 | $6.79 | $41,514.06 | -0.1% | -61.9% | -86.6% | |
| Jan 13, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 6,971 | $6.88 | $47,942.65 | - | -64.0% | -86.4% | |
| Jan 6, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 15,162 | $6.95 | $105,439.14 | -0.1% | -63.3% | -86.5% | |
| Jan 4, 2023 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 55,500 | $7.14 | $396,150.00 | -0.3% | -61.9% | -87.9% | |
| Oct 4, 2022 | KZR Kezar Life Sciences, Inc. | 10% Owner | Sell | 32,312 | $8.78 | $283,814.78 | -0.3% | -18.6% | -88.1% | |
| Jan 11, 2022 | AMLX Amylyx Pharmaceuticals, Inc. | 10% Owner | Buy | 263,158 | $19.00 | $5,000,002.00 | +2.5% | -37.4% | +81.3% | |
| Nov 18, 2021 | APLS Apellis Pharmaceuticals, Inc. | 10% Owner | Buy | 250,000 | $40.00 | $10,000,000.00 | +2.0% | +7.6% | +16.6% |